TriSalus Life Sciences 

$1.01
0
-$0.29-22.31% Today

Statistics

Day High
1.2
Day Low
1.19
52W High
5
52W Low
0.42
Volume
805
Avg. Volume
3,032
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

14MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.96
-0.68
-0.4
-0.12
Expected EPS
-0.158
Actual EPS
N/A

Financials

-341.83%Profit Margin
Unprofitable
2020
2021
2022
2023
18.51MRevenue
-63.28MNet Income

Analyst Ratings

$7.00Average Price Target
The highest estimate is 7.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TLSIW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, Colorado.
Show more...
CEO
Ms. Mary T. Szela B.S.N., M.B.A.
Employees
110
Country
US
ISIN
US89680M1190

Listings

0 Comments

Share your thoughts

FAQ

What is TriSalus Life Sciences stock price today?
The current price of TLSIW is $1.01 USD — it has decreased by -22.31% in the past 24 hours. Watch TriSalus Life Sciences stock price performance more closely on the chart.
What is TriSalus Life Sciences stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange TriSalus Life Sciences stocks are traded under the ticker TLSIW.
When is the next TriSalus Life Sciences earnings date?
TriSalus Life Sciences is going to release the next earnings report on May 14, 2026.
What were TriSalus Life Sciences earnings last quarter?
TLSIW earnings for the last quarter are -0.21 USD per share, whereas the estimation was -0.14 USD resulting in a -47.89% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is TriSalus Life Sciences revenue for the last year?
TriSalus Life Sciences revenue for the last year amounts to 18.51M USD.
What is TriSalus Life Sciences net income for the last year?
TLSIW net income for the last year is -63.28M USD.
How many employees does TriSalus Life Sciences have?
As of April 01, 2026, the company has 110 employees.
In which sector is TriSalus Life Sciences located?
TriSalus Life Sciences operates in the Health Care sector.
When did TriSalus Life Sciences complete a stock split?
TriSalus Life Sciences has not had any recent stock splits.
Where is TriSalus Life Sciences headquartered?
TriSalus Life Sciences is headquartered in Westminster, US.